Seeing Is Believing
Healthcare - Sector
KRYS is currently covered by 8 analysts with an average price target of $245.94. This is a potential upside of $48.43 (24.52%) from yesterday's end of day stock price of $197.51.
Krystal Biotech's activity chart (see below) currently has 112 price targets and 96 ratings on display. The stock rating distribution of KRYS is 88.89% BUY and 11.11% HOLD.
Analysts average stock forecasts to be materialized ratio is 79.86% with an average time for these price targets to be met of 281.08 days.
Highest price target for KRYS is $255, Lowest price target is $166, average price target is $209.
Most recent stock forecast was given by ALEC STRANAHAN from BAML on 16-Oct-2025. First documented stock forecast 17-Oct-2017.
Currently out of the existing stock ratings of KRYS, 24 are a BUY (88.89%), 3 are a HOLD (11.11%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$255
$68.87 (37.00%)
$192
15 days ago
(16-Oct-2025)
3/4 (75%)
$64.77 (34.05%)
284
Buy
$240
$53.87 (28.94%)
$240
1 months 17 days ago
(14-Sep-2025)
24/36 (66.67%)
$84.29 (54.13%)
210
Buy
$216
$29.87 (16.05%)
$219
2 months 10 days ago
(21-Aug-2025)
7/14 (50%)
$65.51 (43.53%)
409
Hold
$166
$-20.13 (-10.82%)
$215
2 months 27 days ago
(04-Aug-2025)
2/5 (40%)
$28.65 (20.86%)
94
Buy
$202
$15.87 (8.53%)
$130
5 months 25 days ago
(06-May-2025)
4/5 (80%)
$65.2 (47.66%)
352
What is KRYS (Krystal Biotech) average time for price targets to be met?
Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?
Which analyst has the most public recommendations on KRYS (Krystal Biotech)?
Which analyst is the currently most bullish on KRYS (Krystal Biotech)?
Which analyst is the currently most reserved on KRYS (Krystal Biotech)?